{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:59:42Z","timestamp":1775548782640,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12985-018-1067-7","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T11:44:55Z","timestamp":1538394295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment"],"prefix":"10.1186","volume":"15","author":[{"given":"Dengke","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"key":"1067_CR1","doi-asserted-by":"publisher","first-page":"16996","DOI":"10.3748\/wjg.v20.i45.16996","volume":"20","author":"S Siramolpiwat","year":"2014","unstructured":"Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World J Gastroenterol. 2014;20:16996\u20137010.","journal-title":"World J Gastroenterol"},{"key":"1067_CR2","first-page":"5211","volume":"18","author":"HS Heinzow","year":"2012","unstructured":"Heinzow HS, Lenz P, Kohler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol. 2012;18:5211\u20138.","journal-title":"World J Gastroenterol"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1067\/j.cpsurg.2016.06.006","volume":"53","author":"AE Ertel","year":"2016","unstructured":"Ertel AE, Chang AL, Kim Y, Shah SA. Management of gastrointestinal bleeding in patients with cirrhosis. Curr Probl Surg. 2016;53:366\u201395.","journal-title":"Curr Probl Surg"},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.5604\/16652681.1198800","volume":"15","author":"N Toshikuni","year":"2016","unstructured":"Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol. 2016;15:314\u201325.","journal-title":"Ann Hepatol"},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1586\/17474124.2016.1122523","volume":"10","author":"MJ Williams","year":"2016","unstructured":"Williams MJ, Hayes P. Improving the management of gastrointestinal bleeding in patients with cirrhosis. Expert Rev Gastroenterol Hepatol. 2016;10:505\u201315.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/hep.21907","volume":"46","author":"G Garcia-Tsao","year":"2007","unstructured":"Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W, Practice guidelines Committee of the American Association for the study of liver D, practice parameters Committee of the American College of G. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922\u201338.","journal-title":"Hepatology"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715\u201328.","journal-title":"Gastroenterology"},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000444551","volume":"34","author":"G Garcia-Tsao","year":"2016","unstructured":"Garcia-Tsao G. Current Management of the Complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Dig Dis. 2016;34:382\u20136.","journal-title":"Dig Dis"},{"key":"1067_CR9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.21580","volume":"45","author":"GC Nguyen","year":"2007","unstructured":"Nguyen GC, Segev DL, Thuluvath PJ. Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology. 2007;45:1282\u20139.","journal-title":"Hepatology"},{"key":"1067_CR10","first-page":"220","volume":"86","author":"TL Tytle","year":"1993","unstructured":"Tytle TL, Loeffler C, Thompson WM 3rd. Transjugular intrahepatic portosystemic shunt (TIPS): a promising nonsurgical treatment for bleeding gastroesophageal varices. J Okla State Med Assoc. 1993;86:220\u20134.","journal-title":"J Okla State Med Assoc"},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1053\/gast.2003.50088","volume":"124","author":"AJ Sanyal","year":"2003","unstructured":"Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, McCashland T, North American study for the treatment of refractory ascites G. The north American study for the treatment of refractory ascites. Gastroenterology. 2003;124:634\u201341.","journal-title":"Gastroenterology"},{"key":"1067_CR12","first-page":"687","volume":"12","author":"Y Goykhman","year":"2010","unstructured":"Goykhman Y, Ben-Haim M, Rosen G, Carmiel-Haggai M, Oren R, Nakache R, Szold O, Klausner J, Kori I. Transjugular intrahepatic portosystemic shunt: current indications, patient selection and results. Isr Med Assoc J. 2010;12:687\u201391.","journal-title":"Isr Med Assoc J"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/hep.23383","volume":"51","author":"TD Boyer","year":"2010","unstructured":"Boyer TD, Haskal ZJ, American Association for the Study of liver D. The role of Transjugular intrahepatic portosystemic shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology. 2010;51:306.","journal-title":"Hepatology"},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1365-2036.1996.60202000.x","volume":"10","author":"EH Forrest","year":"1996","unstructured":"Forrest EH, Stanley AJ, Redhead DN, McGilchrist AJ, Hayes PC. Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis. Aliment Pharmacol Ther. 1996;10:801\u20136.","journal-title":"Aliment Pharmacol Ther"},{"key":"1067_CR15","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","volume":"332","author":"A Ochs","year":"1995","unstructured":"Ochs A, Rossle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med. 1995;332:1192\u20137.","journal-title":"N Engl J Med"},{"key":"1067_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","volume":"46","author":"Y Narahara","year":"2011","unstructured":"Narahara Y, Kanazawa H, Fukuda T, Matsushita Y, Harimoto H, Kidokoro H, Katakura T, Atsukawa M, Taki Y, Kimura Y, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol. 2011;46:78\u201385.","journal-title":"J Gastroenterol"},{"key":"1067_CR17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.jvir.2010.05.009","volume":"21","author":"CL Anderson","year":"2010","unstructured":"Anderson CL, Saad WE, Kalagher SD, Caldwell S, Sabri S, Turba UC, Matsumoto AH, Angle JF. Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience. J Vasc Interv Radiol. 2010;21:1370\u20136.","journal-title":"J Vasc Interv Radiol"},{"key":"1067_CR18","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2014.01.015","volume":"60","author":"JM Perarnau","year":"2014","unstructured":"Perarnau JM, Le Gouge A, Nicolas C, d'Alteroche L, Borentain P, Saliba F, Minello A, Anty R, Chagneau-Derrode C, Bernard PH, et al. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol. 2014;60:962\u20138.","journal-title":"J Hepatol"},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1111\/j.1440-1746.2010.06400.x","volume":"25","author":"Z Yang","year":"2010","unstructured":"Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K, Fan D. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1718\u201325.","journal-title":"J Gastroenterol Hepatol"},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/1756283X16671286","volume":"10","author":"X Qi","year":"2017","unstructured":"Qi X, Tian Y, Zhang W, Yang Z, Guo X. Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials. Therap Adv Gastroenterol. 2017;10:32\u201341.","journal-title":"Therap Adv Gastroenterol"},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1148\/radiology.187.2.8475283","volume":"187","author":"JM LaBerge","year":"1993","unstructured":"LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, Roberts JP, Ascher NL. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993;187:413\u201320.","journal-title":"Radiology"},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1471-230X-9-89","volume":"9","author":"G Tarantino","year":"2009","unstructured":"Tarantino G, Citro V, Conca P, Riccio A, Tarantino M, Capone D, Cirillo M, Lobello R, Iaccarino V. What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol. 2009;9:89.","journal-title":"BMC Gastroenterol"},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-230X-9-21","volume":"9","author":"G Tarantino","year":"2009","unstructured":"Tarantino G, Citro V, Esposito P, Giaquinto S, de Leone A, Milan G, Tripodi FS, Cirillo M, Lobello R. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol. 2009;9:21.","journal-title":"BMC Gastroenterol"},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.3748\/wjg.v20.i20.6262","volume":"20","author":"CM Tang","year":"2014","unstructured":"Tang CM, Yau TO, Yu J. Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments. World J Gastroenterol. 2014;20:6262\u201378.","journal-title":"World J Gastroenterol"},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.28547","volume":"64","author":"J Bissonnette","year":"2016","unstructured":"Bissonnette J, Garcia-Pagan JC, Albillos A, Turon F, Ferreira C, Tellez L, Nault JC, Carbonell N, Cervoni JP, Abdel Rehim M, et al. Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension. Hepatology. 2016;64:224\u201331.","journal-title":"Hepatology"},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cgh.2015.06.042","volume":"14","author":"K Berry","year":"2016","unstructured":"Berry K, Lerrigo R, Liou IW, Ioannou GN. Association between Transjugular intrahepatic portosystemic shunt and survival in patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:118\u201323.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1067_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.cgh.2011.06.013","volume":"9","author":"HK Bhogal","year":"2011","unstructured":"Bhogal HK, Sanyal AJ. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis. Clin Gastroenterol Hepatol. 2011;9:936\u201346 quiz e123.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"Suppl 3","key":"1067_CR28","doi-asserted-by":"publisher","first-page":"S344","DOI":"10.1097\/MCG.0b013e318157e500","volume":"41","author":"L Colombato","year":"2007","unstructured":"Colombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol. 2007;41(Suppl 3):S344\u201351.","journal-title":"J Clin Gastroenterol"},{"key":"1067_CR29","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1111\/j.1572-0241.2001.05340.x","volume":"96","author":"M Rossle","year":"2001","unstructured":"Rossle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol. 2001;96:3379\u201383.","journal-title":"Am J Gastroenterol"},{"key":"1067_CR30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","volume":"114","author":"M Casado","year":"1998","unstructured":"Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, Escorsell A, Rodriguez-Laiz JM, Gilabert R, Feu F, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998;114:1296\u2013303.","journal-title":"Gastroenterology"},{"key":"1067_CR31","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1097\/MEG.0b013e3282eeb488","volume":"19","author":"E Biecker","year":"2007","unstructured":"Biecker E, Roth F, Heller J, Schild HH, Sauerbruch T, Schepke M. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2007;19:846\u201352.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1067_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1440-1746.2005.03601.x","volume":"20","author":"F Membreno","year":"2005","unstructured":"Membreno F, Baez AL, Pandula R, Walser E, Lau DT. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed. J Gastroenterol Hepatol. 2005;20:474\u201381.","journal-title":"J Gastroenterol Hepatol"},{"key":"1067_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2011.12.008","volume":"16","author":"O Riggio","year":"2012","unstructured":"Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Clin Liver Dis. 2012;16:133\u201346.","journal-title":"Clin Liver Dis"},{"key":"1067_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","volume":"53","author":"O Riggio","year":"2010","unstructured":"Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, Fanelli F, Merli M, Salvatori FM. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol. 2010;53:267\u201372.","journal-title":"J Hepatol"},{"key":"1067_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jgh.12725","volume":"30","author":"HK Tan","year":"2015","unstructured":"Tan HK, James PD, Sniderman KW, Wong F. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion. J Gastroenterol Hepatol. 2015;30:389\u201395.","journal-title":"J Gastroenterol Hepatol"},{"key":"1067_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jhep.2016.10.025","volume":"66","author":"J Trebicka","year":"2017","unstructured":"Trebicka J. Emergency TIPS in a child-Pugh B patient: when does the window of opportunity open and close? J Hepatol. 2017;66:442\u201350.","journal-title":"J Hepatol"},{"key":"1067_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","volume":"133","author":"F Salerno","year":"2007","unstructured":"Salerno F, Camma C, Enea M, Rossle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology. 2007;133:825\u201334.","journal-title":"Gastroenterology"},{"key":"1067_CR38","doi-asserted-by":"publisher","first-page":"e79637","DOI":"10.1371\/journal.pone.0079637","volume":"8","author":"H Chen","year":"2013","unstructured":"Chen H, Bai M, Qi X, Liu L, He C, Yin Z, Fan D, Han G. Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS. PLoS One. 2013;8:e79637.","journal-title":"PLoS One"},{"key":"1067_CR39","first-page":"771","volume":"52","author":"T Fejfar","year":"2006","unstructured":"Fejfar T, Safka V, Hulek P, Vanasek T, Krajina A, Jirkovsky V. MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS. Vnitr Lek. 2006;52:771\u20136.","journal-title":"Vnitr Lek"},{"issue":"Suppl","key":"1067_CR40","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2004.11.015","volume":"42","author":"F Durand","year":"2005","unstructured":"Durand F, Valla D. Assessment of the prognosis of cirrhosis: child-Pugh versus MELD. J Hepatol. 2005;42(Suppl):S100\u20137.","journal-title":"J Hepatol"},{"key":"1067_CR41","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0016-5085(03)00377-9","volume":"124","author":"TD Boyer","year":"2003","unstructured":"Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124:1700\u201310.","journal-title":"Gastroenterology"},{"key":"1067_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1053\/j.tvir.2009.04.003","volume":"11","author":"TW Clark","year":"2008","unstructured":"Clark TW. Management of shunt dysfunction in the era of TIPS endografts. Tech Vasc Interv Radiol. 2008;11:212\u20136.","journal-title":"Tech Vasc Interv Radiol"},{"key":"1067_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1053\/gast.1997.v112.pm9041251","volume":"112","author":"AJ Sanyal","year":"1997","unstructured":"Sanyal AJ, Freedman AM, Luketic VA, Purdum PP 3rd, Shiffman ML, DeMeo J, Cole PE, Tisnado J. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997;112:889\u201398.","journal-title":"Gastroenterology"},{"key":"1067_CR44","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","volume":"126","author":"C Bureau","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, Perreault P, Peron JM, Abraldes JG, Bouchard L, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology. 2004;126:469\u201375.","journal-title":"Gastroenterology"},{"key":"1067_CR45","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","volume":"27","author":"C Bureau","year":"2007","unstructured":"Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM, Rousseau H, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007;27:742\u20137.","journal-title":"Liver Int"},{"key":"1067_CR46","doi-asserted-by":"publisher","first-page":"e5680","DOI":"10.1097\/MD.0000000000005680","volume":"95","author":"X Qi","year":"2016","unstructured":"Qi X, Tian Y, Zhang W, Zhao H, Han G, Guo X. Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2016;95:e5680.","journal-title":"Medicine (Baltimore)"},{"key":"1067_CR47","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","volume":"103","author":"O Riggio","year":"2008","unstructured":"Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, Merli M. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008;103:2738\u201346.","journal-title":"Am J Gastroenterol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1067-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-018-1067-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-018-1067-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T03:03:51Z","timestamp":1569899031000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-018-1067-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/s12985-018-1067-7","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"assertion":[{"value":"14 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by Ethics Committees of both China-Japan Union Hospital and 302 Military Hospital on December 2016.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"151"}}